Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
CA 2335382 A1 · Owner: Miron, Daphna · Inventors: Ayal-Hershkovitz, Maty; Ben-Artzi, Hanna; Miron, Daphna
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Qualitative and quantitative methods of testing an agent for its potential at inhibiting glycosidase catalytic activity the methods including the steps of , interacting a glycosidase enzyme with a glycosidase substrate in a presence of the agent and qualitatively or quantitatively evaluating an effect of the agent on the catalytic activity of the glycosidase enzyme toward the glycosidase substrate. Preferably the glycosidase enzyme is a heparanase enzyme and the glycosidase substrate is respectively, a heparanase substrate.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 12, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 12, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 12, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.